Jean-pierre Pouget
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Preclinical PET characterization of [68Ga]Ga-EMP-100 for non-invasive assessment of c-Met in NSCLC.
Journal: EJNMMI research
Published: March 04, 2026
Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor Combinations.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 30, 2026
Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing.
Journal: Methods in cell biology
Published: January 25, 2025
Optical (Cherenkov) dosimetry to unravel the radiobiological effects of radioisotope based therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 21, 2025
MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 08, 2024
Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetry.
Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Published: September 27, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 22, 2024
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 16, 2024
Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 15, 2023
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors.
Journal: Trends in cancer
Published: July 04, 2023
Clonogenic assay to measure bystander cytotoxicity of targeted alpha-particle therapy.
Journal: Methods in cell biology
Published: January 29, 2023
Last Updated: 09/26/2026